Angiotensin-converting enzyme inhibitor in a human model of restenosis
作者： G. R. Heyndrickx
DOI: 10.1007/978-3-642-72497-8_12
关键词: Myocardial infarction 、 Artery 、 Angiotensin-converting enzyme 、 Cardiology 、 Internal medicine 、 Coronary artery disease 、 Blood flow 、 Bypass grafting 、 Restenosis 、 In patient 、 Medicine
摘要: Percutaneous transluminal coronary angioplasty (PTCA) was introduces by Andreas Gruentzig in 1977, as an alternative treatment for artery bypass grafting (CABG) to restore blood flow patients with obstructive disease (15). Increased experience and advances technology have resulted a high primary success rate (over 90%) low compilation (death, non-fatal myocardial infarction; 4–5%) (9). However, the late restenosis (17% 40%) still limits long-term benefit of procedure (21, 23, 47, 52).
springer.com
sci-hub.st 参考文章(48)
A Hammacher, U Hellman, A Johnsson, A Ostman, K Gunnarsson, B Westermark, A Wasteson, C H Heldin, A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain Journal of Biological Chemistry. ,vol. 263, pp. 16493- 16498 ,(1988) , 10.1016/S0021-9258(18)37619-1
Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Circulation. ,vol. 86, pp. 100- 110 ,(1992) , 10.1161/01.CIR.86.1.100
G Dorros, M J Cowley, J Simpson, L G Bentivoglio, P C Block, M Bourassa, K Detre, A J Gosselin, A R Grüntzig, S F Kelsey, K M Kent, M B Mock, S M Mullin, R K Myler, E R Passamani, S H Stertzer, D O Williams, Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation. ,vol. 67, pp. 723- 730 ,(1983) , 10.1161/01.CIR.67.4.723
Richard M. Fleming, Richard L. Kirkeeide, Richard W. Smalling, K.Lance Gould, Yvonne Stuart, Patterns in visual interpretation of coronary arteriograms as detected by quantitative coronary arteriography. Journal of the American College of Cardiology. ,vol. 18, pp. 945- 951 ,(1991) , 10.1016/0735-1097(91)90752-U
Jerry S. Powell, Rita K. M. Müller, Marianne Rouge, Herbert Kuhn, Fridolin Hefti, Hans R. Baumgartner, The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. Journal of Cardiovascular Pharmacology. ,vol. 16, ,(1990) , 10.1097/00005344-199016004-00010
Andreas R. Grüntzig, Åke Senning, Walter E. Siegenthaler, Nonoperative Dilatation of Coronary-Artery Stenosis New England Journal of Medicine. ,vol. 301, pp. 61- 68 ,(1979) , 10.1056/NEJM197907123010201
A J Naftilan, R E Pratt, V J Dzau, Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. Journal of Clinical Investigation. ,vol. 83, pp. 1419- 1424 ,(1989) , 10.1172/JCI114032
S. R. Hanson, J. S. Powell, T. Dodson, A. Lumsden, A. B. Kelly, J. S. Anderson, A. W. Clowes, L. A. Harker, Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension. ,vol. 18, ,(1991) , 10.1161/01.HYP.18.4_SUPPL.II70
M W Majesky, M A Reidy, D F Bowen-Pope, C E Hart, J N Wilcox, S M Schwartz, PDGF ligand and receptor gene expression during repair of arterial injury. Journal of Cell Biology. ,vol. 111, pp. 2149- 2158 ,(1990) , 10.1083/JCB.111.5.2149
J R Wilentz, T A Sanborn, C C Haudenschild, C R Valeri, T J Ryan, D P Faxon, Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation. ,vol. 75, pp. 636- 642 ,(1987) , 10.1161/01.CIR.75.3.636